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Abstract
Spinal cord contusion injury leads to severe loss of gray and white matter and subsequent deficit of motor and sensory
functions below the lesion. In this study, we investigated whether application of murine clonal embryonic neuroecto-
dermal stem cells can prevent the spinal cord secondary damage and induce functional recovery. Stem cells (NE-GFP-4C
cell line) were grafted intraspinally or intravenously immediately or one week after thoracic spinal cord contusion injury.
Control animals received cell culture medium or fibrin intraspinally one week after injury. Functional tests (Basso, Beattie,
Bresnahan, CatWalk) and detailed morphological analysis were performed to evaluate the effects of grafted cells. Stem
cells applied either locally or intravenously induced significantly improved functional recovery compared with their
controls. Morphologically, stem cell grafting prevented the formation of secondary injury and promoted sparing of the
gray and white matters. The transplanted cells integrated into the host tissue and differentiated into neurons, astrocytes,
and oligodendrocytes. In intraspinally grafted animals, the corticospinal tract axons regenerated along the ventral border of
the cavity and have grown several millimeters, even beyond the caudal end of the lesion. The extent of regeneration and
functional improvement was inversely related to the amounts of chondroitin sulphate and ephrin-B2 molecules around the
cavity and to the microglial and astrocytic reactions in the injured segment early after injury. The grafts produced glial cell
derived neurotrophic factor, macrophage inflammatory protein-1a, interleukin (IL)-6 and IL-10 in a paracrine fashion for
at least one week. Treating the grafted cords with neutralizing antibodies against these four factors through the use of
osmotic pumps nearly completely abolished the effect of the graft. The non-significant functional improvement after
function blocking is likely because the stem cell derivatives settled in the injured cord. These data suggest that grafted
neuroectodermal stem cells are able to prevent the secondary spinal cord damage and induce significant regeneration via
multiple mechanisms.
Keywords: functional recovery; paracrine mechanism; regeneration; spinal cord injury; stem cells
Introduction
Spinal cord injury (SCI) results in irreversible tissue damageaccompanied by motor, sensory, and vegetative function losses
and is followed by very limited recovery of function.1,2 Although
the physical damage caused by the injury cannot be overcome,
secondary injuries can be prevented partially.3–8 In addition to this,
recently serious efforts have been made to render the microenvi-
ronment of the lesion permissive to growing axons, thus promoting
regeneration within the damaged cord. Therapeutic strategies
aiming at fostering regeneration included the down-regulation of
several axonal growth-inhibiting factors such as ephrins and their
receptors,9–12 myelin-derived inhibitors,13–15 and the chondroitin-
sulphate family.16,17
In the last decades, intensive efforts to restore the lost integrity of
the injured spinal cord included the use of various neuroprotective
substances, such as riluzole and cell-based therapeutic approaches.
Some of the stem cell-based therapeutic applications were able to
induce both morphological and functional neuroprotection ands in
some cases regeneration.18–23
Earlier studies from our laboratory have provided evidence that
the immortalized neuroectodermal stem cell line NE-GFP-4C
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(ATCC No.: CRL-2936), derived from the forebrain vesicle wall of
p53-deficient nine-day–old mouse embryos24 effectively prevents
the death of motoneurons destined to die after a spinal ventral root
avulsion injury. The NE-GFP-4C cells have been shown to dif-
ferentiate to neurons, astrocytes, and oligodendrocytes after
transplantation into the spinal cord with a damaged motoneuron
pool and induced the rescue of the vast majority of the injured
motoneurons.25,26 It has been proven that the grafted cells’ secre-
tome induced by the motoneuron damage was able to support
motoneuron survival.26
Based on the capacity of NE-GFP-4C cells being able to rescue
severely injured motoneurons and promote the regeneration of their
axons, we hypothesized that transplantation of these cells into a
contused spinal cord may lead to robust morphological regenera-
tion and restoration of function after injury. The aim of the present
study was to investigate the changes in the microenvironment of the
injured cord after transplantation of NE-GFP-4C cells.
Methods
Maintenance of NE-GFP-4C stem cells
The NE-GFP-4C clonal neuroectodermal stem cells (ATCC No.
CRL-2926) were isolated from forebrain vesicles of nine-day–old
embryos of transgenic mice lacking the tumor suppressor gene p53,
and they were made to produce eGFP as described previously.24
The NE-GFP-4C cells were maintained on Nunc Petri dishes
(Invitrogen, Austria) in High glucose Dulbecco Modified Essential
Medium (H-DMEM, Sigma, Austria) supplemented with 10% fetal
calf serum (FCS, Gibco, ThermoFischer Scientific, Waltham, MA)
at 37C and 5% CO2.
SCI model
All together, 90 female Sprague-Dawley rats (Animal Research
Laboratories, Himberg, Austria, 180–220 g body weight) were
used. All of the operations were performed under deep ketamine-
xylazine anesthesia (ketamine hydrochloride [Ketavet, 110 mg/kg
body weight]; xylazine [Rompun, 12 mg/kg body weight]) and
sterile precautions. Laminectomy was performed at the thoracic 11
(T11) vertebral level, the dura mater was exposed, and the spinal
cord was contused using an Infinity Horizon impactor (IH-0400,
PSI LLC, Glendale, CA), applying 150 kdyn force. All animals
were allowed to survive two, three, or eight weeks after injury.
The experiments were performed with the approval of the Ani-
mal Protocol Review Board of City Government of Vienna re-
garding the care and use of animals for experimental procedures.
All the procedures were performed according to the Helsinki De-
claration on Animal Rights. Animals were given food and water ad
libitum.
Transplantation of NE-GFP-4C stem cells
and experimental groups
Immediately or one week after injury, NE-GFP-4C cells were
transplanted intravenously or intraspinally (depending on the ex-
perimental setup) using Hamilton pipettes. Intravenously 1· 106
(delivered in 250 microliter medium), intraspinally 5· 105 stem
cells (delivered in 2 microliter) were injected into the tail vein or
into the lesion cavity, respectively. In the case of intraspinal ap-
plication, a one week delay of the transplantation was applied based
on the study by Pe´ron and associates.27 This study has shown that
such delay of the transplantation significantly enhances the survival
and proliferation of the grafted cells.27
In a separate experimental group, stem cells were grafted in-
traspinally mixed with human fibrin clot matrix (Baxter Healthcare
Corporation, Westlake Village, CA, 500 IU/mL, human). Control
animals received medium or fibrin intraspinally or medium intra-
venously one week or medium intravenously immediately after
injury.
The following experimental groups (n = 10) were established in
this study:
1. Fibrin-1w-isp: fibrin was injected intraspinally one week
after injury (control).
2. Medium-1w-isp: medium was injected intraspinally one
week after injury (control).
3. Medium-immed-iv: medium was injected intravenously
immediately after injury (control).
4. Medium-1w-iv: medium was injected intravenously one
week after injury (control).
5. NE4C-fibrin: stem cells in fibrin were transplanted in-
traspinally one week after injury.
6. NE4C-immed-iv: stem cells were transplanted intravenously
immediately after injury.
7. NE4C-1w-iv: stem cells were transplanted intravenously one
week after injury.
8. NE4C-1w-isp: stem cells were transplanted intraspinally one
week after injury.
Further, two groups (n = 5) were set up in separate experiments
using function blocking antibodies; for details, see below.
9. NE4C-isp-blocking: function blocking antibodies were used
intraspinally after one week of injury.
10. NE4C-isp-isospecific: isospecific antibodies were used in-
traspinally after one week of injury (control).
Retrograde labeling
Eight weeks after surgery, five animals with long-term survival
(groups 1, 2, 5, 6, 7, 8) were deeply anesthetized as described
above. The L3 spinal segment was exposed, and a right hemisection
was performed. Fast Blue (FB) crystals (Illing Plastics GmbH,
Gross-Umfeld, Germany) were placed into the gap, and the wound
was closed. Seven days after the application, the animals were
reanesthetized and perfused transcardially. Sections taken from the
brain and spinal cord were cut in a cryostat (Leica CM-1850, Leica
GmbH, Germany) and mounted onto gelatinized slides. The num-
ber of FB-positive cells was determined using an epifluorescent
microscope (BX-50, Olympus, Japan).
Anterograde labeling
In the long-term survival groups (8 weeks survival, groups 1, 2,
5, 6, 7, and 8, n= 5 animals in each group), the rats were anesthe-
tized, and the left hind limb area of the motor cortex was micro-
injected stereotaxically with 4· 2lL of biotinylated dextran-amine
(BDA, MW 10000; Molecular Probes) in phosphate buffered saline
(PBS).28 One week after the BDA administration, animals were
reanesthetized and perfused transcardially. After cryosectioning,
the BDA-labeled fibers were visualized by using the Tyramide
Alexa protocol. For camera lucida drawings, three parasagittal
sections were used and the camera lucida drawings were super-
imposed on each other.
Sacrifice of animals and maintenance of samples
After various survival times (2, 3, or 8 weeks after injury), an-
imals were anesthetized and perfused transcardially with saline
containing heparin followed by 4% paraformaldehyde (PFA) in
0.1 mol/L phosphate buffer (pH 7.4). The spinal cord, brainstem,
and the brain of the animals were removed and placed into 4%
buffered PFA for one day. The fixed tissues were cryoprotected in
30% sucrose in PBS containing 0.01% sodium-azide at 4C until
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being embedded in Shandon Cryomatrix gel (ThermoFischer Sci-
entific, United Kingdom). Parallel or serial transverse (25lm thick)
and longitudinal (16lm thick) sections were cut and mounted onto
gelatine-coated glass slides.
Immuno- and lectin histochemistry
Non-specific binding sites were blocked subsequently with 3%
normal donkey, goat, or horse serum. Primary antibodies and lectin
were used as follows: rat anti-M6 (mouse-specific neuron marker,
DSHB, 1:400), rat anti-M2 (mouse-specific astrocyte marker,
DSHB, 1:400), rat anti-MOG (mouse-specific oligodendrocyte
marker, R&D Systems, 1:50, MAB2439), rabbit anti-glial fibrillary
acidic protein (GFAP) (Life Technologies, 1:400, 18-0063),
chicken anti-beta(III)-tubulin (Merck-Millipore, 1:1000, ab9354),
rabbit anti-beta(III)-tubulin (1:1000, Abcam, ab18207), rabbit anti-
neurofilament 200kD (1:500, Abcam, ab8135), chicken anti-green
fluorescent protein (GFP) (Merck-Millipore, 1:1000, ab16901),
mouse anti-CS-56 (1:200, SIGMA, C8035), rabbit anti-Eph-A4
(1:500, Santa Cruz Biotechnology, sc-20721), goat anti-ephrin-B2
(1:500, Santa Cruz Biotechnology, sc-19227), biotinylated Grif-
foniaSimplicifoliaisolectin B4 (1:200, Vector, B1205), rabbit anti-
IL-1-alpha (1:200, Abbiotech, 250715), goat anti-IL-6 (1:200,
R&D Systems, AF-406-NA), rat anti-IL-10 (1:200, BioLegend,
505011), rabbit anti-tumor necrosis factor (TNF)-alpha (1:200,
Abbiotech, 250844), goat anti-macrophage inflammatory protein
(MIP)-1-alpha (1:200, R&D Systems, AF-450-NA), rabbit anti-
NT-4/5 (1:200, Abbiotech, 250792), rabbit anti-brain-derived
neurotrophic factor (BDNF) (1:200, Abcam, ab72439), rabbit anti-
glial cell derived neurotrophic factor (GDNF) (1:200, Abcam,
ab18956), rabbit anti-vascular endothelial growth factor (VEGF)
(1:200, Santa Cruz Biotechnology, sc-507), rabbit anti-platelet-
derived growth factor (PDGF)-A (1:200, Santa Cruz Biotechnology,
sc-7958), rabbit anti-5-hydroxytryptamine (HT) (1:100, Abcam,
ab10385) and goat anti-matrix metalloproteinase (MMP)-2 (1:200,
Santa Cruz Biotechnology, sc-6838).
The following secondary antibodies were used: biotinylated
horse anti-goat immune globulin G (IgG) (H+L, BA9500), bioti-
nylated goat anti-rabbit IgG (H+L, BA1000), biotinylated horse
anti-mouse IgG (H+L, BA2001), biotinylated goat anti-chicken
IgG (H+L, BA9010) (1:200, all from VECTOR). The immune re-
action was completed by using Alexa Fluor 546 donkey anti-goat
(1:400, Thermo Fischer Scientific, A11056), Alexa Fluor 546 goat
anti-rabbit IgG (1:400, Thermo Fischer Scientific, A11010), Alexa
Fluor 594 donkey anti-rat IgG (1:400, Thermo Fischer Scientific,
A-21209), Streptavidin Alexa Fluor 546 Conjugate (1:400, Thermo
Fischer Scientific, S-11225), Streptavidin Alexa Fluor 405 Con-
jugate (1:400, Thermo Fischer Scientific, S-32351), or the Alexa
Fluor 546 TSA kit (1:800, Tyramide Signal Amplification; Thermo
Fischer Scientific, T20933).
Fluorescent images were obtained by using an epifluorescent
microscope (BX-50, Olympus, Japan) or a compact confocal mi-
croscope (FluoView FV10i, Olympus, Japan).
Quantitative assessment of anterograde
and retrograde tracing
For quantifying anterograde labeled corticospinal axons, analysis
was performed according to Hill and colleagues.28 The BDA-labeled
corticospinal axons were examined in every fourth paramedian
section (16 lm thick) of the injured spinal cord. The labeled axons
were visualized through the use of streptavidin Alexa Fluor 546
(1:400, Thermo Fischer Scientific, S-11225). A zero point was
determined as the rostralmost part of the cavity. Fifteen lines,
perpendicular to the rostrocaudal axis, were drawn 0.5 mm apart
from 2 mm rostral to 5 mm caudal from the zero point; axons that
crossed these lines were counted at 40 ·magnification.
To normalize the number of BDA labeled corticospinal axons
in various groups, the total number of fibers was quantified 7 mm
rostral to the cranial end of the lesion cavity, and the percentage of
total axons crossing the designated lines caudal to this point was
determined.
The number of retrograde labeled neurons was determined ac-
cording to Bunge.29 Serial transverse sections (30lm thick) were
taken from the T5, T2, C6, and C2 spinal segments, and every fifth
or every tenth coronal section (30lm thick) was used from the
brainstem or from the cerebral cortex, respectively. In the spinal
cord serial sections, the FB-labeled neurons were mapped, and their
location was compared with that of the labeled neurons in the
neighboring sections. Thus, double counting of the same neuron
was avoided.19 In the case of brainstem and cortex sections, the
number of FB-labeled neurons was determined in each section, and
the final numbers were multiplied by five or 10, respectively.
Quantification of cavity length, cystic area,
and tissue sparing
Every second transverse section from the T7–L1 segments
containing the lesion cavity was stained with cresyl violet. The
border between the intact tissue and the lesion cavity composed of
small cysts was defined. Cavity length was determined by using
the following equation: cavity length (mm) = section thickness
(lm)· number of sections.
The whole cystic cross sectional area (lesion cavity area) at the
level of the epicenter was determined as follows: the number of
pixels of the reference area (1 mm2) and that of the cystic area was
computed through the use of the NIH ImageJ analysis software
(imagej.nih.gov/ij). The pixel number of the cystic area was di-
vided by that of the reference area, and the result was expressed
in mm2.
The percentage of spared white and gray matter was determined
in a similar manner. Briefly, the number of pixels of the spared
white and gray matter was measured at the epicenter (0) and 0.3,
0.6, 0.9, and 1.2 mm rostrally and caudally from it. Identical spinal
cord segments of intact animals were used as reference values. The
amount of spared white and gray matter in the lesioned animals was
given as percentage of intact spinal cord values.
Quantification of 5-HT density
For quantifying serotonergic fibers, analysis was performed
according to Karimi-Abdolrezaee and coworkers.30 To assess 5-HT
immunoreactivity, photographs were taken from cross sections of
L2 ventral horns. The relative density of 5-HT immunoreactivity
was measured in the animals of the medium-1w-isp, NE4C-immed-
iv, NE4C-1w-iv, and NE4C-1w-isp groups (n = 4 in each). To de-
termine the final density, the background of unstained samples as
reference intensity was subtracted from the intensity of immuno-
reactive samples. The density was then normalized to the uninjured
value.
Quantification of ephrin-B2, Eph-A4, GFAP, GSA-B4,
and CS56 reactions two and three weeks after injury
To assess the density of ephrin-B2+, Eph-A4+, GFAP+, GSA-
B4+, and CS-56+ reactivities in spinal cords of injured and treated
animals (n = 4 in each group), two sagittal sections (150lm apart)
containing the lesion cavity were analyzed for each marker. Mi-
crophotographs were taken, and the whole spinal cord section area
including the cavity and a 2 mm long extension of the tissue ros-
trally and caudally from the cavity ends was analyzed. After
measuring the relative densities (ImageJ, National Institutes of
Health), the values of transplanted spinal cords were divided by the
relevant densities of the injured cords (control animals) and
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multiplied by 100. The background intensity of unstained samples
was individually subtracted from the intensity of treated sections.
Quantification of host-derived GDNF, IL-6, IL-10,
and MIP-1 alpha
To quantify the density of immunoreactivity of the four secre-
tome factors in spinal cords of medium-1w-isp and NE4C-1w-isp
animals (n= 4 animals in each group), two sagittal sections (150lm
apart) excluding the lesion or grafted area were analyzed for each
marker. Using the Image J software, we measured the relative
density of immunochemical fluorescence signal of four factors
along a 2 mm long extension of the tissue rostrally and caudally
from the cavity ends or grafted area taking the total width of the
cord. Then, the GDNF, IL-6, IL-10, and MIP-1 alpha intensities
were divided by the outlined area to calculate the mean net intensity/
unit area. We determined the level of background/autofluorescence
by imaging unstained samples. This reference intensity was then
subtracted from the average intensity to determine the net final
density.
Function-blocking antibody experiments
Animals (n = 5 in each set of experiments) were anaesthetized
deeply, and contusion injury was performed as described above.
One week after the contusion injury, the animals were grafted as
described above, and a miniosmotic pump (Alzet Osmotic Pumps,
Cupertino, CA; type 1002, 100 lL volume, actively pumping for 2
weeks) filled with a mixture of function-blocking antibodies against
GDNF (AF-212-NA), IL-6 (AF-406-NA), MIP-1a (AF-450-NA)
(4lg/mL working concentration, all from R&D Systems, Minnea-
polis, MN), and IL-10 (Biolegend, San Diego, CA, 505011) was
placed subcutaneously in the dorsal region (group 9., NE4C-intraspin-
blocking). All antibodies were specific to mouse epitopes only.
A silicone tube (Degania Silicone Ltd, Kibbutz Degania, Israel,
0.3 mm in internal diameter) extended from the minipump to the
spinal cord, and its distal end was inserted into the dorsal part of the
cord at the site of grafting into the contusion cavity. The tube was
fixed to the surrounding musculature with 8-0 sutures (Ethilon) to
avoid moving in or out of the spinal cord.
Control animals received NE-GFP-4C stem cell grafts and
pumps filled with identical volumes of antibody-specific IgG iso-
types only including polyclonal goat IgG for the replacement of
GDNF, IL-6, MIP-1-alpha antibodies, and monoclonal rat IgG2A
for the replacement of IL-10 antibody (4 lg/mL working concen-
tration, all from R&D Systems, Minneapolis, MN) (group 10,
NE4C-intraspin-isospecific). Motor function was evaluated weekly
for eight weeks by applying the Basso, Beattie, Bresnahan (BBB)
test.31 After eight weeks survival time, rats were processed for
histological analysis.
Analysis of locomotion pattern—CatWalk
gait analysis
To determine and analyze the parameters of the movement
pattern, the CatWalk automated quantitative gait analysis system32
(Noldus Ltd, The Netherlands) was used (n= 8 each in groups 1–8,
except group 5 where the analysis could not be performed). The
following parameters were taken into account during the analysis:
max area, print area, stride length, swing duration, and swing speed.
We measured these parameters eight weeks after the injury. Ani-
mals had a two-week–long training period before the contusion
injury. Data were evaluated by the CatWalk software.32,33
Open field test
In the long-term survival groups (8 weeks), motor function was
evaluated by the BBB test31 three days after the injury and then
once a week for eight weeks. Two observers, unaware of experi-
mental procedures, tested the animals (n= 8 in each group, except
groups 9 and 10 where n= 4).
Statistical analysis
The paired t test or the one-way analysis of variance (ANOVA)
or the two-way ANOVA test followed by the Tukey all pairwise
multiple comparison procedure were used to compare the data.
Results
General observations, functional improvement,
and CatWalk gait analysis
The BBB open field test was used at regular intervals to assess
locomotor recovery. After the contusion injury, all animals dis-
played strong motor impairment. During the first week, no weight
supported stepping was observed in all groups (Fig. 1A). Intraspinal
application of stem cells (NE4C-1w-isp) or medium (medium-1w-
isp) on week 1 after the injury induced a plateau in locomotor
recovery for one week. This phenomenon is because of the mini-
mally invasive nature of intraspinal grafting of cells or injection of
medium. In contrast, systemic application of stem cells (NE4C-
immed-iv, NE4C-1w-iv) or medium (medium-1w-iv) did not in-
duce any drop in locomotor recovery (Fig. 1A).
Four weeks after the injury, the animals that received intraspinal
grafts displayed the same BBB scores as the intravenously grafted
groups. From five to eight weeks after injury, consistent plantar
stepping with predominant parallel paw position and consistent
fore- and hindlimb coordination could be observed in the animals
that received systemic and intraspinal grafts. Interestingly, animals
whose spinal cord cavity was filled with NE-GFP-4C cells mixed
with fibrin (NE4C-fibrin) had more impaired locomotion than their
controls (fibrin-1w-isp; Fig. 1A,B). These animals showed occa-
sional weight supported dorsal or plantar stepping without fore- and
hindlimb coordination.
The results of the automated gait analysis (CatWalk) confirmed
our functional observations on freely moving animals (Fig. 1C).
We evaluated the print and maximum area of hindlimb, swing
duration, swing speed, and stride length eight weeks after injury.
The animals of the NE4C-fibrin group could not be processed for
CatWalk analysis because these rats displayed only occasional
weight support. The functional recovery was significantly im-
proved in the intravenously and intraspinally grafted groups
(NE4C-immed-iv, NE4C-1w-iv, and NE4C-1w-isp) compared
with their controls.
Stem cells induce tissue sparing
Within the injured segment, a large, centrally located cystic
cavity was formed containing cellular debris. The morphological
analysis involved measuring the rostrocaudal distribution of spared
gray and white matter in the injured segments eight weeks after the
injury. Both the intravenous and intraspinal application of stem
cells resulted in significantly improved tissue sparing relative to the
controls. The highest percentage of spared tissue was detected in
those animals that received intraspinal grafts (NE4C-1w-isp)
(Supplementary Fig. S1A; see online supplementary material at
www.liebertpub.com). The intravenously treated animals (NE4C-
immed-iv and NE4C-1w-iv) also displayed high, but non-significantly
lower amount of spared tissue compared with the intraspinally
treated animals (Fig. S1A). The greatest amount of white matter
localized to the ventral and ventrolateral parts of the spinal cord in
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these groups. In contrast, in animals treated with stem cells mixed
with fibrin (NE4C-fibrin), the spared white and gray matter was
smaller than in all the other groups (Fig. S1A).
The basic parameters of the cavity such as lesion area at the
epicenter and length of the cavity on week eight after the injury
revealed that both the intravenously and intraspinally treated ani-
mals (NE4C-immed-iv, NE4C-1w-iv, NE4C-1w-isp) had signifi-
cantly smaller cavity length and lesion area than their controls. No
significant difference was found in animals that received their stem
cells embedded in fibrin (NE4C-fibrin) compared with their control
group (Supplementary Fig. S1B,C; see online supplementary ma-
terial at www.liebertpub.com).
Retrograde neuronal tracing analysis
Next, we evaluated whether axonal regeneration/sparing was
promoted by the grafted stem cells. Retrograde labeling with
the fluorescent dye FB from the right L3 segment revealed that
significantly higher numbers of FB-labeled propriospinal neurons
were found in the T5, T2, C6, and C2 spinal segments in animals
treated with stem cells (NE4C-immed-iv, NE4C-1w-iv, and NE4C-
1w-isp) than in their controls. The number of retrogradely labeled
neurons in the NE4C-fibrin group was not statistically different
from the control groups (Fig. 2A).
Both the total number of FB cells in the brainstem and their
number in the selected brainstem nuclei (reticular formation, lateral
vestibular nucleus, and inferior olivary nucleus) projecting distally
to the lesion site were significantly higher compared with their
controls. This was also the case for layer V neurons in the motor
cortex whose axons rarely were able to project into the distal spinal
cord. Only the intraspinally grafted animals (NE4C-1w-isp)
showed an exception because these rats displayed significantly
greater numbers of retrograde labeled pyramidal cells compared
with the controls and the intravenously grafted animals (NE4C-
immed-iv, NE4C-1w-iv; Fig. 2A).
FIG. 1. Locomotor analysis of the grafted animals and their controls. (A) Open field locomotor test (Basso, Beattie, Bresnahan [BBB])
shows significant improvement in all grafted animals compared with their controls, except the NE4C-fibrin one, which showed a decline
of their locomotor pattern from week 6 onward. (B) Enlarged view of the graphs in A from week 5 onward. Note the grouping of
locomotor scores in the grafted and control groups except for the NE4C-fibrin animals. Asterisk represents significant difference
between each grafted group and its control at various time points (with exception of the NE4C-fibrin group). (C) Semiautomated
CatWalk gait analysis of the animals in the various groups eight weeks after injury. Note the significantly improved parameters of the
grafted animals compared with their controls. The NE4C-fibrin animals could not be evaluated in the CatWalk locomotor analysis
system because in many instances they did not produce well-recordable runs. Data are expressed as mean – standard error of the mean. *,
significant difference between the intraspinally or intravenously grafted animals with the control ones. Color image is available online.
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In contrast, the raphe nuclei of animals that received intraspinal
grafts (NE4C-1w-isp) displayed significantly more FB-labeled
neurons than those of intravenously grafted animals (NE4C-
immed-iv, NE4C-1w-iv) or their controls (Fig. 2B).
Preservation of serotonergic innervation
after intraspinal grafting
Serotonergic fibers reportedly exert strong supraspinal influence
on locomotion.34–36 Sprouting of the remaining 5-HT+ fibers
caudal to a contusion injury is found to be limited by successful
therapeutic approaches.30 Accordingly, descending serotonergic
fiber density was measured caudal to the injury in the ventral horn
of the L2 spinal segment of intravenously and intraspinally grafted
animals (NE4C-immed-iv, NE4C-1w-iv, NE4C-1w-isp) and in the
control group (medium-1w-isp). We found a 5-to-5.7–fold increase
of 5-HT+ fiber density in the control and in the intravenously
grafted groups. In contrast, a small, 1.8-fold increase of density was
observed in the intraspinally grafted animals compared with the
uninjured value (Fig. 2B).
Anterograde corticospinal tracing analysis
Our retrograde labeling studies have suggested that significantly
greater numbers of corticospinal axons were spared or have re-
generated in the intraspinally grafted animals. To distinguish
FIG. 2. Morphometric analysis of the connections between the segments caudal to the lesion and various parts of the central nervous system
cranial to that. (A) Numbers of neurons retrograde labeled from the right L3 hemisegment. Note the significantly higher numbers of labeled
cells in the grafted animals compared with their controls, especially in the brainstem. The greatest number of retrograde labeled cells was
always found in the intraspinally treated animals. (B) Retrograde labeling results in the raphe nuclei (left panel) and serotonergic immu-
nochemical densities (right panel) expressed as fold increase caudal to the lesion normalized to the uninjured level. Note the considerable
number of retrograde labeled raphe neurons and the lack of sprouting in the NE4C-1w-isp animals. Data are expressed as mean– standard
error of the mean. *, significant difference between the intraspinally or intravenously grafted animals with the control ones.
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FIG. 3. Regeneration of corticospinal tract (CST) fibers in the spinal cords of NE4C-1w-isp animals. (A) Paramedian sagittal section of a
representative NE4C-1w-isp spinal cord showing the biotinylated dextran-amine (BDA)–labeled CST fibers. The images of three neighboring
sections are superimposed to show the significant numbers of regenerating axons. (B) Many dorsally growing fibers reach the cranial end of
the cavity where they form axon growth cone-like structures and aborted, club-like endings (see enlarged framed area B in B¢ and B†).
(C) Considerable numbers of regenerating axons form a new pathway along the ventral edge of the cavity. Some of them still display growth
cone-like structure at their tips eight weeks after injury (see boxed area C¢ enlarged in C†). (D) Few axons get diverted at this level and grow
perpendicular to the longitudinal axis of the cavity. (E) Regenerating axons re-enter the original pathway and then grow along the vacated fiber
tract. Enlarged boxes E¢ and E† show the course of these fibers. Scale bars: A: 500lm, B: 100lm, B¢: 50lm, C†: 10lm. (F) Graph shows the
cumulative ratios of anterograde labeled CST fibers in the various experimental groups (100% corresponds to the total number of labeled CST
fibers in the intact cranial part of the cord). Only animals in the NE4C-1w-isp group were able to regenerate their CST axons beyond the caudal
end of the remaining contusion cavity. Data are expressed as mean– standard error of the mean. *, significant difference between NE4C-1w-
isp group with the control group (medium-1w-isp). Color image is available online.
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between spared and regenerating corticospinal axons, we per-
formed anterograde labeling of pyramidal cells in the motor
cortex. The BDA-labeling of pyramidal cells in control animals
displayed retracted corticospinal tract (CST) axons with bulb-like
endings approaching 300 lm at the rostral end of the lesion cavity.
In most of the treated animals, the CST axons were able to reach
the rostral end of the cavity, but did not grow further along
(Supplementary Fig. S2; see online supplementary material at
www.liebertpub.com).
Most interestingly, CST axons in more than half of the in-
traspinally grafted animals (NE4C-1w-isp, three of five animals)
showed profound regeneration. In these animals the CST axons
regenerated all the way along the ventral border of the cavity of the
cord, and a significant number of these regenerating fibers returned
FIG. 4. Fate and differentiation of the grafted NE-GFP-4C cells are shown in the various grafting paradigms. (A,B) The derivatives of
the intravenously grafted NE-GFP-4C cells (A-A¢: NE4C-immed-iv, B-B¢: NE4C-1w-iv) settled in the wall of the contusion cavity one week
after grafting are displayed. Most of the M2-positive cells express glial fibrillary acidic protein (GFAP). A¢ and B¢ show randomly selected
high magnification fields. (C,D) Differentiation of intraspinally grafted NE-GFP-4C cells in the contusion cavity one week after grafting
results in the appearance of glial and neuronal derivatives at the periphery of the graft. Boxed areas are shown in C¢-C† and D¢-D†. C¢-C†: High
numbers of M6 positive neuronal derivatives are expressing beta(III)-tubulin. D¢-D†: M2 positive astroglial cells also co-express GFAP. (E–
G) Intraspinally grafted stem cell derivatives remain in the wall of the cavity at the end of the survival period (eight weeks after grafting).
Apart from the neuronal and glial stem cell-derived cells (E,F), mouse-specific oligodendrocyte marker (MOG) positive oligodendrocytes are
also present in the wall of the cavity (G) and appeared to be in close relation to NF-200 positive axons (G¢). Note that green fluorescent protein
(eGFP) expression pattern diminishes with differentitation (A,B,C,D,E,F,G). Dashed line indicates the graft-host border. A,B: 250lm, A¢, B¢:
20lm, C,D: 500lm, C¢, D¢: 20lm, C†: 10lm; D†: 20lm, E F,G: 250lm, G¢: 10lm. Color image is available online.
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to their original CST pathway at levels caudally to the distal end of
the cavity (Fig. 3A).
These far regenerating axons appeared to grow for distances of
at least 5 mm taken from the rostral end of the cavity (Fig. 3F).
Moreover, axon growth cone-like structures and aborted, club-
like endings could be detected around the rostral end of the
cavity (Fig. 3B, B¢, B†) and along the regenerating ventral
pathway (Fig. 3C, C¢, C†, D). The BDA-labeled fibers were also
found at the caudal end of the cavity (Fig. 3E, E¢, E†). Significant
difference was found in the axon numbers between intraspinally
grafted (NE4C-1w-isp) and the control animals (medium-1w-isp)
(Fig. 3F).
Differentiation of the grafted cells in the injured cord
To determine the differentiation potential of the grafted stem
cells in the injured cord, we analyzed the expression of murine
markers that are able to uniquely identify grafted mouse cells in a
rat environment (Fig. 4). One week after intravenous transplanta-
tion (NE4C-immed-iv, NE4C-1w-iv), only M2-positive astrocytes
could be seen in the injured cord, and all these cells disappeared
by the end of the investigation period. Stem cell-derived astrocytes
settled down mainly in the wall of the cavity and expressed the glial
marker GFAP (Fig. 4A,A¢,B,B¢).
In contrast, the intraspinally grafted stem cells (NE4C-1w-isp)
differentiated into neurons (M6+) and astrocytes (M2+) one week
after transplantation (Fig. 4C,C¢,D,D¢). Stem cell-derived oligo-
dendrocytes could not be detected at this stage. The majority of
these stem cell-derived neurons and astrocytes also expressed
beta(III)-tubulin and GFAP, respectively (Fig. 4C†,D†). The
grafted cells filled the cystic cavity without migrating out of it
to the surrounding spinal cord tissue. At the end of the survival
period stem cell-derived neurons, astrocytes and oligodendro-
cytes (MOG+) were found in the wall of the cavity (Fig. 4E,F,G).
Neurofilament 200kD+ and MOG+ profiles were observed in close
relationship to each other indicating that the stem cell-derived oli-
godendrocytes might have contributed to the remyelination of
naked axons (Fig. 4G¢). The eGFP expression of the grafted cells
had decreased or ceased, suggesting that the eGFP expression
pattern diminishes with differentiation confirmed by our earlier
study, too.26
Modulation of the lesion environment
Next, we investigated whether the grafted cells have the po-
tential to alter the microenvironment of the lesion rendering it
permissive for regenerating axons. Therefore, we examined the
densities of astrocytes and microglia/macrophages, the expression
of Eph-A4 and ehprin-B2 molecules, and the deposition of chon-
droitin sulfate proteoglycan (CSPG) two and three weeks after the
injury around the lesion cavity (Supplementary Fig. S3A,B; see
online supplementary material at www.liebertpub.com). Both in-
traspinal or intravenous applications of stem cells induced significant
reduction of astrocytosis at both time points indicated by signifi-
cantly lower GFAP densities in these cords compared with their
controls. Decreased GFAP densities were accompanied in these
animals by limited CS-56+ depositions (Supplementary Fig. S3A,B).
Strong astrocytic reaction, however, was detected in animals that
received stem cells in fibrin glue (NE4C-fibrin). Accordingly, CS-
56 densities in these animals were as high as in their controls.
Moreover, microglia/macrophage densities paralleled that of the
astrocytes indicating a close link between the proliferation of these
cell types.
Earlier studies have shown that after SCI, EphA receptor sub-
types and their ephrin ligands are upregulated, and these interac-
tions may create an environment that is unfavorable for neurite
outgrowth and functional regeneration.9,37,38 The EphA4-ephrinB2
binding reportedly induces collapse of neural growth cones in the
presence of reactive astrocytes.10,39,40 While EphA4 expression did
not change significantly in the systemic and intraspinal treatment
groups, ephrinB2 expression was found significantly lower in the
intraspinally grafted animals two and three weeks after injury. The
same effect was noted in the systemic treatment group only on week
three (Supplementary Fig. S3A,B; see online supplementary ma-
terial at www.liebertpub.com).
Increased MMP-2 expression in the graft two weeks
after injury
The MMPs are thought to regulate the composition and permis-
siveness of the extracellular matrix.41 Within this family, MMP-2
has been reported to prevent the development of massive glial scar
tissue after central nervous system (CNS) injury.42–44 Accordingly,
expression of MMP-2 both in the host cord and the graft was ana-
lyzed two weeks after injury using immunohistochemistry.
In the spinal cords of the control animals (medium-1w-isp),
modest MMP-2 immunoreactivity was detected in the cavity wall
of the spinal cords at the level of the epicenter, gradually decreasing
toward both ends of the cavity (Supplementary Fig. S4A,A¢; see
online supplementary material at www.liebertpub.com). More in-
creased MMP-2 expression was found in the NE4C-immed-iv and
NE4C-1w-iv groups mainly locating to the epicenter, but in contrast
with the medium-1w-isp group, MMP-2 displayed more intense
expression in the host tissue (Supplementary Fig. S4B,B¢,C,C¢).
Strong MMP-2 immunoreaction was detected in the grafted cells
and in the cavity wall of NE4C-1w-isp rats (Supplementary
Fig. S4D,D¢,E,E¢,E†). The MMP-2 expression was highest in the
middle of the graft and appeared to be significantly weaker toward
its cranial and caudal ends.
Factors produced by grafted stem cells induce
functional recovery in the intraspinally grafted animals
In the case of intraspinal grafting, the transplanted cells are
apposed to the wall of the cavity. The fact that only limited numbers
of graft-derived cells settled in the wall of the cavity suggested that
there is a paracrine secretory mechanism acting on the host spinal
cord. To determine the factors secreted by the grafted cells, we
analyzed the expression of 10 factors (IL-1-alpha, IL-6, IL-10,
TNF-alpha, MIP-1-alpha, NT-4/5, BDNF, GDNF, VEGF, PDGF-
A), thought to exert beneficial effects on the damaged cord.
Four of the 10 factors were found to be expressed in the graft
(GDNF, IL-6, IL-10 and MIP-1a) (Fig. 5). The GDNF showed
strong expression patterns both in the host cord and in the graft
(Fig. 5A,A¢,A†). Strong IL-6 expression was confined to the grafted
cells accompanied by weaker staining in the host spinal cord
(Fig. 5B, B¢, B†). The IL-10 and MIP-1a expressions showed
similar distribution patterns to that of GDNF, but the expression of
these two factors within the host cord was restricted to the tissue
located ventral to the cavity (Fig. 5C,C¢,C†,D,D¢,D†).
Interestingly, the control group animals (medium-1w-isp) that
did not receive any graft showed no expression of the various
factors (Fig. 5E,F,G,H). Comparison of immunoreactivity of all
four factors across the control (medium-1w-isp) and grafted
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(NE4C-1w-isp) experimental spinal cords revealed a robust in-
crease in GDNF, IL-6, IL-10, and MIP-1 alpha expression in the
host tissue of grafted group (Fig. 5I).
To test whether these three cytokines and GDNF are indeed
responsible for inducing the rescue and regeneration of the host
neurons, we used osmotic minipumps to infuse the mixture of
function blocking mouse-specific antibodies produced against all
four factors to the grafts in a separate set of animals (NE4C-isp-
blocking). Motor recovery of the hindlimbs was evaluated, and the
results were compared with those of the control (medium-1w-isp)
and intraspinally treated group (NE4C-1w-isp; Fig. 6). Blocking of
function of the proteins produced by the grafted cells resulted in
similarly poor recovery as found in control animals (Fig. 6A).
Despite the use of neutralizing antibodies, the grafted stem cells
survived and differentiated to the same extent as the stem cells
within the intraspinally grafted animals (Fig. 6B,B¢,C,C¢,D,D¢).
To test whether active immunoglobulins used in these experiments
do not have a neutralizing effect on the grafted stem cells, osmotic
FIG. 5. Expression of the various factors produced by the intraspinally grafted NE-GFP-4C stem cells and host spinal cord
tissue one week after grafting. (A–D): The graft and the host tissues express glial cell derived neurotrophic factor (GDNF),
interleukin (IL-)6, IL-10, and macrophage inflammatory protein (MIP)-1a. A¢–D¢ show the strong expression pattern of these factors
within the graft (boxed areas taken from the graft region). In contrast, A†–D† show the interface region between the graft (g) and the
host (h) tissues with varying extent of expression intensity in the host (boxed areas taken from the graft-host interface). (E–H) None
of these factors was found to be expressed in the spinal cords of control animals (medium-1w-isp). (I) Quantification of all four
factors revealed an increased level of GDNF, IL6, IL-10, and MIP-1a immunoreactivity in intraspinally grafted group (NE4C-1w-isp)
compared with controls (medium-1w-isp). Dashed line indicates the graft-host border. Data are expressed as mean – standard error of
the mean. *, significant difference between NE4C-1w-isp group with the control group (medium-1w-isp). Scale bars: A–H: 500 lm,
A¢–D¢, A†–D†: 100 lm. Color image is available online.
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pumps filled with a mixture of isotype-specific IgGs were used to
deliver these IgGs to the site of grafting (NE4C-isp-isospecific).
No significant difference relative to the intraspinally grafted an-
imals was found (Fig. 6A).
Expression of IL-10 in intravenous groups
In the intravenously treated animals (NE4C-immed-iv, NE4C-
1w-iv), only IL-10 was found to be expressed at im-
munohistochemically detectable levels. Expression of IL-10 was
confined mainly to the internal margin of the cavity and to its wall
composed of host tissue (Supplementary Fig. S5A,A¢,B,B¢, re-
spectively; see online supplementary material at www.liebertpub
.com). To determine the source of IL-10, we performed immu-
nohistochemical double labeling. Astrocytes were found to ex-
press IL-10 around the cavity (Fig. S5C). In the internal marginal
zone of the cavity, round GSA-B4-positive macrophages dis-
played IL-10 immunoreactivity (Fig. S5D).
Discussion
Grafted stem cells induce tissue sparing, axonal
sparing/regeneration, and functional recovery
Both intraspinal and intravenous application of NE-GFP-4C
cells promoted tissue sparing in the injured cords. The significant
amount of spared white matter made it possible to maintain the
temporarily disrupted connections between the intact regions above
and below the injury site. The considerable white matter sparing is
supported by the fact that the lumbar cords of grafted animals
displayed limited sprouting of 5-HT fibers compared with control
cords. The limited sprouting may indicate the presence of a higher
number of supplying 5-HT fibers as supported by our retrograde
labeling studies.
On the other hand, it became evident from the anterograde la-
beling studies of the CST tract that, apart from tract sparing, a
significant number of descending CST fibers was able to regenerate
along a new pathway, and this regeneration was supported by the
permissive environment around the lesion. Although not investi-
gated, it can be argued that similar to the CST tract, other minor and
major tracts may have regenerated, too. The rescue of gray matter
and short propriospinal tracts may also have contributed to the
functional restoration of the damaged cords.45,46 These consider-
able morphological improvements observed in the grafted cords led
to the significant functional recovery.
In our study, a higher number of retrograde labeled brainstem
neurons could be detected in stem cells grafted groups compared
with controls. Regeneration of brainstem neurons is essential for
locomotor functional recovery in the rat after SCI.47,48 Thus, re-
generation/sparing of these neurons has the potential to improve
functional recovery if they reach or retain their connection with the
targets distal to the lesion.
The spinal serotonergic pathway showed axonal sprouting,
which may play a pivotal role in neuromodulation and locomo-
tion.34,35 Previous studies have demonstrated that increased 5-HT
fiber density in the injured spinal cord contributes to improved
functional recovery.49,50 In contrast, we found that increased
FIG. 6. Functional blocking of the factors produced by the stem cells with neutralizing antibodies abolishes the motor recovery in
grafted animals. (A): Open field locomotor test (Basso, Beattie, Bresnahan) shows that grafted animals (NE4C-isp-blocking) treated
with neutralizing antibodies against the four secretome factors produce as little recovery as control rats (medium-1w-isp). Animals
treated with isospecific immune globulin G (IgGs) (NE4C-1w-isp-isospecific) showed considerable improvement. The non-significant
difference between NE4C-1w-isp and NE4C-1w-isp-isospecific groups is likely because of the effect of the implanted osmotic pump
and tube. (B–D): Grafted animals treated with neutralizing antibodies also displayed surviving stem cell-derived astroglial cells (B, B¢),
neurons (C,C¢), and oligodendrocytes in close relationship with NF-200 positive axons (D,D¢). The presence of stem cell-derived cells
may be responsible for the non-significant difference between NE4C-isp-blocking and medium-1w-isp groups. Data are expressed as
mean – standard error of the mean. *, significant difference between the intraspinally grafted animals with the control ones. B,C:
500 lm, B¢,C¢: 100lm, D,D¢: 50lm. Color image is available online.
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density of sprouting serotonergic fibers below the lesion was not
associated with significantly improved recovery of locomotion. It
could be argued that serotonergic fiber preservation in the grafted
animals did induce less sprouting than that observed in control
animals, where the remaining serotonergic axons likely produced
considerably sprouting.
These data further suggest that an aligned and target-oriented
supraspinal innervation of spinal cord regions distal to the injury
may act more effectively than abundant and uncontrolled sprouting
of these fibers. These data accord with the finding that in the in-
traspinally grafted animals, higher numbers of raphe neurons were
retrograde labeled from segments distal to the lesion, indicating a
preserved aligned 5-HT fiber tract structure with lower 5-HT
densities in these segments. This is contrasted by the fewer retro-
grade labeled raphe cells associated with higher 5-HT fiber densi-
ties in the other experimental groups, suggesting considerable
sprouting derived from the fewer surviving axons.
Microenvironment in the grafted cords is permissive
for regenerating axons
In this study, we have demonstrated that NE-GFP-4C grafting
induced significantly lower astrocyte/microglia reaction than found
in the control spinal cords. This resulted in lower amounts of CS-56
and ephrin-B2 in the microenvironment of the lesion, and these
favorable changes rendered the glial scar permissive for axonal
regeneration.51,52 Moreover, the matrix metalloproteinase isozyme
MMP-2 reportedly shows an inverse expression pattern with the
amount of the developing glial scar tissue after SCI. Higher levels
of MMP-2 densities may suggest the development of less dense
glial scar in the injured cord by regulating the formation of a glial
scar and white matter sparing and/or axonal plasticity.42,53 In the
spinal cords of the grafted animals, significantly higher densities of
MMP-2 were observed within the graft and in the surrounding host
tissue than in control cords.
It can be argued that these above outlined changes (astro-
cyte/microglia downregulation along with associated low densities
of CS-56 and ephrin-B2 and upregulation of MMP-2 production)
all induced an altered lesion microenvironment that promoted the
regeneration of injured axons.
It was surprising to see that human fibrin treatment alone did not
improve the functional outcome or gliosis of the lesion site. More-
over, animals treated with NE-GFP-4C cells embedded in human
fibrin had more impaired functional outcome and more extensive
gliosis than the control animals, including its own control group. This
phenomenon can be explained on the basis of recent findings that
prove the rather negative effect of mammalian fibrin matrices on the
injured spinal cord in contrast to non-mammalian (salmon) fibrin.54
It can also be argued that the disintegrating mammalian fibrin matrix
may have induced a consequent degeneration/death of the grafted
stem cells leading to tertiary damage within the contused cords re-
placing the regenerative effects of the stem cells.
Factors contributing to functional recovery
Our results suggest that the grafted stem cells may contribute to
the improved functional recovery after contusion injury by a dual
mechanism. It appears evident that the grafted cells produce a set of
cytokines (IL-6, IL-10, and MIP-1a) and GDNF. Functional blocking
of these factors produced by the grafted cells in the intraspinal
grafting group have provided evidence that they play a major role in
the functional recovery process compared with the effect of stem cell
derivatives that remained in the wall of the lesion cavity.
It could be argued that the non-significant difference found in the
functional improvement of the animals that received functional
blocking treatment compared with their controls may be because of
the presence of various stem cell derivatives (neurons, astrocytes,
and myelinating oligodendrocytes) around the lesion cavity. The
low number of these cells suggests that other minor effects may
have contributed to this difference in the functional outcome.
These findings support the hypothesis that in the case of in-
traspinal grafting of NE-GFP-4C stem cells, the mechanism of
action is based on the major paracrine immunomodulatory and
neurotrophic effect and on a minor cellular replacement mecha-
nism. The fact that in the intravenous grafting groups only IL-10
was expressed around the lesion and no stem cell derivatives were
found at the end of the survival period explains the somewhat
limited efficacy of this grafting method.
The intravenous application of NE-GFP-4C cells was able to
reduce the microglia/macrophage reactions in the affected spinal
cord segments. These results suggest that intravenously applied
NE-GFP-4C cells may exert their primary effects outside the spinal
cord perhaps by altering the immune-mediated secondary patho-
logical events after SCI. This phenomenon requires further studies
to elucidate the mechanism.
Our findings have shown clearly that the paracrine effect was
exerted by the undifferentiated stem cells only soon after grafting.
As reported by our laboratory earlier, NE-GFP-4C cells do not
produce any of these factors in culture.26 Accordingly, the grafted
cells start factor production after a short period after grafting, and
this suggests the presence of a strong communicative interaction
between the injured host tissue and the grafted cells.
The efficacy of GDNF to enhance axonal growth through and
beyond the injury site has been proven by several studies.25,55,56
Moreover, local spinal neurons and glial cells can also be rescued
by GDNF treatment during the acute phase of the injury,57 and
neosynaptogenesis has reportedly been enhanced as well.58 The IL-
6 proved to be neuroprotective against excitotoxicity-induced cell
death in the CNS via distinct pathways.59,60 In vitro administration
of IL-6 enhances neurite outgrowth of neurons accompanied by
increased expression of growth associated genes.61
The IL-10 is a strong anti-inflammatory cytokine of the immune
system and has a neuroprotective effect in the CNS, too. Admin-
istration of IL-10 after traumatic or excitotoxic SCI promoted
survival of the injured neurons and improved the motor recovery by
acting on the injured neurons.62 The exact role of MIP-1a is not
fully understood in the injured CNS, but our laboratory showed that
it has a role in the motoneuron survival after SCI.63
Conclusion
We can state that grafted NE-GFP-4C neuroectodermal stem
cells induce robust regeneration and neuroprotection in the injured
spinal cord. This effect is because of paracrine secretion mecha-
nism of the transplanted cells producing GDNF, MIP-1a, IL-6, and
IL-10. Only a minor, non-significant improvement may be induced
by stem cell-derived neurons and glia settled in the wall of the
contusion cavity. The secreted factors appeared to have rendered
the microenvironment axonal growth-permissive and prevented the
death of damaged neurons and glial cells otherwise destined to die.
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